Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer

Stock News

06/29

Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.

The certificate pertains to the "Fully Automated Chemiluminescence Immunoassay Analyzer." The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.

This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1147852283"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147852283\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147852283?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147852283","market":"sh","top_or_hot":-1,"title":"Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer","media":"Stock News","content":"<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTellgen Corporation's Subsidiary Secures Medical Device Registration for Fully Automated Chemiluminescence Immunoassay Analyzer\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-06-29 18:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.<br><br>The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.<br><br>This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of <b>Tellgen Corporation</b> and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物醫藥B類股","start_time":0,"source_url":"","article_id":"1147852283","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147852283","pubTimestamp":1782727224,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300642":"透景生命","BK1574":"生物医药B类股","BK0042":"基因检测","BK0239":"医药制造","BK0046":"生物疫苗","09996":"沛嘉医疗-B","BK1583":"高瓴概念","BK1100":"医疗保健设备"},"translate_title":"Tellgen Corporation子公司获得全自动化学发光免疫分析仪医疗器械注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300642":1,"09996":1},"content_text":"Tellgen Corporation (SZSE: 300642) has announced that its wholly-owned subsidiary, Jiangxi Tellgen Life Technology Co., Ltd., has recently obtained a medical device registration certificate from the Jiangxi Provincial Medical Products Administration.The certificate pertains to the \"Fully Automated Chemiluminescence Immunoassay Analyzer.\" The acquisition of this registration enriches the instrument portfolio supporting the company's and the subsidiary's chemiluminescence product line.This development is expected to facilitate the expansion of the company's products across various application scenarios. It will further strengthen the overall competitiveness of Tellgen Corporation and its subsidiary within the in-vitro diagnostics field and is anticipated to enhance market expansion capabilities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}